Mirae Asset Global Etfs Holdings Ltd. Cabaletta Bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 23,559 shares of CABA stock, worth $70,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,559
Previous 21,797
8.08%
Holding current value
$70,912
Previous $163,000
31.9%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
126Shares Held
47.9MCall Options Held
202KPut Options Held
110K-
Jennison Associates LLC5.63MShares$17 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$14.3 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$12.4 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.67MShares$11.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$9.14 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $87.3M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...